SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-21-106374
Filing Date
2021-08-16
Accepted
2021-08-16 16:30:34
Documents
4
Period of Report
2021-09-21

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm2123771d2_def14a.htm DEF 14A 400939
2 GRAPHIC tm2123771d2_def14aimg001.jpg GRAPHIC 5408
3 GRAPHIC tm2123771d2_def14aimg002.jpg GRAPHIC 333694
4 GRAPHIC tm2123771d2_def14aimg003.jpg GRAPHIC 288562
  Complete submission text file 0001104659-21-106374.txt   1267127
Mailing Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850
Business Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850 (734) 332-7800
Synthetic Biologics, Inc. (Filer) CIK: 0000894158 (see all company filings)

IRS No.: 133808303 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-12584 | Film No.: 211178841
SIC: 2834 Pharmaceutical Preparations